A multi-national, randomized phase II/III study with Caelyx vs Caelyx/carboplatin vs weekly paclitaxel/carboplatin in patients with platinum-resistant epithelial ovarian cancer after first or second-line chemotherapy
Latest Information Update: 08 Jun 2015
Price :
$35 *
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Carboplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Therapeutic Use
- Acronyms PROVE
- 20 Nov 2006 New trial record.